Additionally, we conducted an analysis on the efficacy of PSMA PET/CT in T staging and established a cutoff value for SUVmax that might aid in distinguishing between PCa and non-PCa lesions. This evidence concerns the gene FOLH1 and posterior cortical atrophy.